In particular, the presence of compounds such as costunolide and dehydrocostus lactone, which are known for their anti-cancer activities and roles in promoting ROS, likely enhances the effectiveness of combined AR and HT treatment [68,69,70]. The gene discussed is AR; the disease is cancer.